Risk factors

SentinelOne faces new regulatory pressures under EU DORA and Data Act requirements.

SailPoint added risks regarding AI adoption, heightened geopolitical cyber attacks, and international IP enforcement. Debt facilities were restructured to a 5-year 250.0 million dollar credit facility.

Satellogic faces risks from uninsurable in-orbit satellite failures and orbital debris. Dilution has occurred via multiple share offerings totaling millions. AI tool adoption and defense export controls add operational compliance risks.

SilverBox Corp IV faces risks primarily driven by its proposed business combination with Parataxis. High shareholder redemptions could threaten the $25 million minimum cash condition. The lack of an underwriter due diligence process adds risk for public investors.

Company abandoned its wound care business to pivot into a blockchain-based asset strategy focused on SKY tokens and staking.

Signet added new risks covering artificial intelligence, recent acquisitions like Diamonds Direct and Blue Nile, and climate impacts on diamond mining. Commodity costs, mall traffic, and foreign sourcing remain core business vulnerabilities.

Added artificial intelligence and dilution risks, while dropping tenant concentration and ESG scrutiny disclosures.

Trade-policy changes could impose tariffs on imported pharmaceuticals and ingredients, including a threatened 100% tariff on branded or patented drugs.

Future Phase 3 trials may face FDA diversity-plan requirements, while enrollment delays could raise costs and extend timelines.

Snail added nine new risks highlighting executive leadership changes, foreign jurisdiction hurdles, debt covenants, and stablecoin initiatives. Financial pressures intensified with new Nasdaq delisting notices, short-term debt updates, and expanding convertible note dilution. Tax volatility spiked as the effective tax rate dropped to negative 64.6 percent.

Spire Global faces severe going concern pressures, relying on a volatile marketable securities portfolio valued at $57.0 million at year-end 2025.

STKS added a new risk concerning shifting consumer dining preferences, including the popularity of weight loss drugs.